BIRB 796 BS, low dose

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Arthritis, RheumatoidHealthyPsoriasis

Phase 1

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

CompletedNCT02209805

Boehringer IngelheimHealthy

Start: 2001-01-31Updated: 2014-08-06

Phase 2

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

CompletedNCT02209753

Boehringer IngelheimPsoriasis

Start: 2001-06-30Updated: 2014-08-06

Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis

TerminatedNCT02214888

Boehringer IngelheimArthritis, Rheumatoid

Start: 2003-05-31Updated: 2014-08-13